precise-2-logo

SYST-EUR

Cochrane systematic review for first line treatment for hypertension

Trial
Journal Ref. Staessen JA, Fagard R, Thijs L, Celis H, Arabidze GG, Birkenhager WH, Bulpitt CJ, de Leeuw PW, Dollery CT, Fletcher AE, et al: Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Lancet 1997, 350:757-764.
Intervention Drug - anti-hypertensives
Number of sites 198
Countries involved East and West Europe
Sample size 4695
Type of statistical analyses
Risk of bias Overall: Low Risk details
Duration of trial
Primary outcome Stroke
Primary analysis - To what extent areall data included?Primary outcome - Howrelevant is it toparticipants?Follow-up - How closely areparticipants followed-up?Flexibility - What measures are in place to makesure participants adhere to the intervention?Flexibility - How should the intervention bedelivered?Organisation - What expertiseand resources are needed todeliver the intervention?Setting - Where is the trialbeing done?Recruitment - How are participantsrecruited into the trial?Eligibility - Who is selected to participate in the trial?12345 wheel.svg
Show Score Ranges

Scores:

(shows median if more than one score was entered)

Elig. Recr. Setting Org. Int. Flex. Del. Flex. Adherence Follow-Up Prim. Out. Prim. An.
1 5 5 3 4 5 2 3 5

View Scores Back to List